FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,276 letters match. Newest first.
-
DrugsSpecialty Process Labs LLC
FDA warned Specialty Process Labs about manufacturing quality failures for thyroid USP active ingredient, including unvalidated processes and data control gaps.
High risk -
DrugsInhousepharmacy.vu
Vanuatu online pharmacy Inhousepharmacy.vu sold unapproved domperidone to US consumers over the internet.
High risk -
DrugsDavid Cosmetic Co., Ltd.
FDA lab testing found benzene, a cancer-causing impurity, at about 6 ppm in David Cosmetic's CALA hand sanitizer, making it adulterated.
High risk -
DrugsBrigham and Women’s Hospital Inc.
Brigham and Women’s Hospital PET drug facility had water leaks and fungal contamination in aseptic areas, FDA says.
High risk -
DrugsDelta 8 Hemp
FDA warned Delta 8 Hemp over unapproved Delta-8 THC drugs and adulterated gummies sold online.
High risk -
DrugsATLRx, Inc.
FDA warned ATLRx that its CBD and Delta-8 THC products are unapproved drugs with illegal disease claims.
High risk -
DrugsKingdom Harvest
Kingdom Harvest marketed CBD and Delta-8 THC products with unapproved drug claims and unsafe food and animal drug uses.
High risk -
DrugsBioMD Plus LLC
FDA warned BioMD Plus LLC that its CBD and Delta-8 THC products are unapproved drugs and its Delta-8 gummies contain an unsafe food additive.
High risk -
DrugsM Six Labs, Inc.
FDA warned M Six Labs over unapproved CBD/Delta-8 THC drugs, illegal CBD/Delta-8 foods, and animal drugs sold online.
High risk -
DrugsMiami University Department of Chemistry and Biochemistry
Miami University contract testing lab falsified heparin API test data and lacked CGMP controls.
High risk -
DrugsAge Management Institute Santa Barbara
FDA cited Age Management Institute Santa Barbara for insanitary sterile compounding of IV drugs, including dirty equipment and expired ingredients.
High risk -
DrugsFroggy’s Fog LLC
FDA warns Froggy’s Fog that its OTC hand sanitizer was made under inadequate CGMP and mislabeled for alcohol strength.
High risk -
DrugsThe W.S. Badger Company, Inc.
FDA warned W.S. Badger over repeat manufacturing-quality failures in OTC drug products, including sunscreen process, cleaning, test-method, and OOS investigation problems.
High risk -
DrugsGuangzhou Zhongkebaishi Health Industry Co., Ltd.
Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.
High risk -
DrugsFresh Farms LLC
FDA warned Fresh Farms LLC about manufacturing violations in OTC hand sanitizer, including untested ethanol and missing batch records.
High risk -
DrugsCetylite Industries, Inc.
FDA warned Cetylite Industries over CGMP violations at its Pennsauken, NJ facility, including unvalidated testing and inadequate OOS investigations for topical anesthetics.
High risk -
DrugsVitae Enim Vitae Scientific Inc.
FDA warned Vitae Enim Vitae Scientific of sterile drug CGMP violations and contamination-control failures after a 2021 inspection, leading to a recall.
High risk -
DrugsClinical Resolution Laboratory Inc.
FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.
High risk -
DrugsKleenhanz, LLC
FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.
High risk -
DrugsElements Brands Inc.
FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.
High risk -
DrugsUltimark Products
Ultimark Products sells Porcelana Day Skin Lightening Cream, an unapproved and misbranded hydroquinone skin-bleaching drug, FDA says.
High risk -
DrugsSkinPro
SkinPro sells an unapproved, misbranded hydroquinone skin-bleaching drug without FDA approval.
High risk -
DrugsSkin PS Brands
FDA warns Skin PS Brands that Dark Spot Fix, a hydroquinone skin-lightening drug, is an unapproved and misbranded new drug.
High risk -
DrugsClinical Formula LLC
FDA warned Clinical Formula LLC that its Clinical Formula Bleaching Lotion is an unapproved and misbranded skin-lightening drug.
Medium -
DrugsNeoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc.
FDA warned Neoteric Cosmetics and parent Scott's Liquid Gold that ALPHA Skin Care Dual Action Fade Cream, a hydroquinone skin lightener, is an unapproved and misbranded drug.
Medium -
DrugsDr. Thomas Balshi/Intilight
FDA warned Dr. Thomas Balshi/Intilight that its hydroquinone skin-lightening cream is an unapproved and misbranded new drug.
High risk -
DrugsSkin Authority, L.L.C.
FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.
High risk -
DrugsAMBI Enterprises LLC
AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.
High risk -
DrugsGenomma Lab USA, Inc.
Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.
High risk -
DrugsM & M Beauty and Wellness, LLC
FDA says M & M Beauty and Wellness sells an unapproved, misbranded hydroquinone skin-lightening cream.
High risk -
DrugsTrue Earth Health Products, LLC
FDA warned True Earth Health Products over Plexaderm Dark Spot Fade Gel, an unapproved, misbranded hydroquinone skin-bleaching drug.
High risk -
Drugs"Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases
FDA warns clinical investigator Daniel C. Tarquinio over enrolling ineligible subjects in investigational drug trials.
High risk -
DrugsVi-Jon, LLC
FDA cited Vi-Jon for manufacturing-rule violations after finding microbial water contamination, leaks, weak investigations, and data-integrity failures in OTC drugs and cosmetics.
High risk -
Drugswww.wellerectile.com
FDA warned India-based www.wellerectile.com over selling unapproved, improperly labeled drugs online, including hydroxychloroquine claimed to treat COVID-19.
High risk -
Drugskubapharm.com
FDA and DEA warned kubapharm.com it unlawfully sells high-abuse-risk stimulants, including Adderall, online without required registrations or prescriptions.
High risk -
Drugspremiumlightsupplier.com
FDA and DEA warned premiumlightsupplier.com that it unlawfully sells Schedule II stimulants, including Adderall, online without prescriptions or DEA registration.
High risk -
DrugsMed Shop Total Care, Inc.
FDA warns Med Shop Total Care about insanitary conditions in sterile drug compounding.
High risk -
DrugsUltra Seal Corporation
FDA warns Ultra Seal and ULTRAtab over manufacturing quality failures in over-the-counter drug cleaning, testing, and release.
High risk -
DrugsGeneritech Corporation
FDA warned Generitech Corporation of Fresno, California over CGMP failures in its topical drug manufacturing and unapproved hydroquinone skin bleaching creams.
High risk -
DrugsYusef Manufacturing Laboratories, LLC
FDA warned Yusef Manufacturing Laboratories over serious CGMP violations in its OTC drugs and hand sanitizers, including untested ethanol.
High risk -
DrugsCofixRx, LLC
FDA warned CofixRx that its CofixRX Nasal Spray is an unapproved, misbranded drug sold with COVID-19 prevention claims.
High risk -
DrugsSensory Cloud, Inc
FDA and FTC warn Sensory Cloud that its FEND nasal mister is an unapproved, misbranded drug sold with COVID-19 prevention and treatment claims.
High risk -
DrugsNDAL Mfg Inc.
NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.
High risk -
DrugsCBD Social
FDA and FTC warn CBD Social over website claims that CBD products prevent or treat COVID-19.
High risk -
DrugsFunctional Remedies, LLC D/B/A Synchronicity Hemp Oil
FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.
High risk -
DrugsGreenway Herbal Products LLC
FDA and FTC warned GreenWay Herbal Products that CBD website claims to prevent and treat COVID-19 make its products unapproved, misbranded drugs.
High risk -
DrugsCureganics
Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.
High risk -
DrugsNature's Highway
FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.
High risk -
DrugsUPSY LLC
FDA and FTC warned UPSY LLC that its website sells CBD products claimed to treat or prevent COVID-19 as unapproved, misbranded drugs.
High risk -
DrugsHeaven’s Organic LLC
FDA and FTC warned Heaven’s Organic LLC over CBD products sold with unapproved COVID-19 treatment and prevention claims.
High risk